Rank #1505RCKT

Rocket Pharmaceuticals, Inc.

$3.74

8.41% (Daily)

Market Cap

$404.75M

Revenue

$N/A

Rank by MCap

#1505

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Gaurav D. Shah M.D.

Headquarters

Cranbury, NJ

Employees

299

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States. It develops vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an in...